会員登録
ログイン
【4599】ステムリム
再生医薬品の研究開発
類似企業：
【業界1位】
小野薬品工業
【業界1位】
小野薬品工業
売上高
営業利益
経常利益
当期利益
{{models[key].tabname}}
| 決算期 | 日付 | 予・実 | 売上高 (百万円) |
対前回 | 修正率 | 修正率 | 営業利益 (百万円) |
対前回 | 修正率 | 修正率 | 経常利益 (百万円) |
対前回 | 修正率 | 修正率 | 当期利益 (百万円) |
対前回 | 修正率 | 修正率 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 2026.07 | 2026/09/09 | 実 | 0 | - | - | - | -1,998 | - | - | - | -1,879 | - | - | - | -1,851 | - | - | - |
| 2025.07 | 2025/09/10 | 実 | 0 | - | - | - | -1,971 | - | - | - | -1,970 | - | - | - | -1,929 | - | - | - |
| 2024.07 | 2024/09/11 | 実 | 0 | - | - | - | -2,076 | - | - | - | -2,077 | - | - | - | -2,022 | - | - | - |
| 2023.07 | 2023/09/13 | 実 | 2,350 | → | 0.0% | 0.0% | 142 | ↓ | -2.7% | -2.7% | 145 | ↓ | -2.7% | -2.7% | 168 | ↓ | -1.2% | -1.2% |
| 2023.07 | 2023/06/14 | Q3予 | 2,350 | → | 0.0% | 0.0% | 146 | → | 0.0% | 0.0% | 149 | → | 0.0% | 0.0% | 170 | → | 0.0% | 0.0% |
| 2023.07 | 2023/04/10 | 当初予 | 2,350 | - | - | - | 146 | - | - | - | 149 | - | - | - | 170 | - | - | - |
| 2022.07 | 2022/09/08 | 実 | 22 | - | - | - | -1,980 | - | - | - | -1,972 | - | - | - | -1,948 | - | - | - |
| 2021.07 | 2021/09/09 | 実 | 1,400 | ↓ | -39.1% | -39.1% | -593 | ↓ | -529.7% | -529.7% | -583 | ↓ | -522.5% | -522.5% | -582 | ↑ | +0.5% | -531.1% |
| 2021.07 | 2021/07/15 | 修正予 | - | - | - | - | - | - | - | - | - | - | - | - | -585 | ↓ | -533.3% | -533.3% |
| 2021.07 | 2021/06/10 | Q3予 | 2,300 | → | 0.0% | 0.0% | 138 | → | 0.0% | 0.0% | 138 | → | 0.0% | 0.0% | 135 | → | 0.0% | 0.0% |
| 2021.07 | 2021/03/11 | Q2予 | 2,300 | → | 0.0% | 0.0% | 138 | → | 0.0% | 0.0% | 138 | → | 0.0% | 0.0% | 135 | → | 0.0% | 0.0% |
| 2021.07 | 2020/12/09 | Q1予 | 2,300 | → | 0.0% | 0.0% | 138 | → | 0.0% | 0.0% | 138 | → | 0.0% | 0.0% | 135 | → | 0.0% | 0.0% |
| 2021.07 | 2020/09/10 | 当初予 | 2,300 | - | - | - | 138 | - | - | - | 138 | - | - | - | 135 | - | - | - |
| 2020.07 | 2020/09/10 | 実 | 2,100 | ↑ | +425.0% | +425.0% | 415 | ↑ | +138.1% | +138.1% | 361 | ↑ | +131.8% | +131.8% | 347 | ↓ | -3.6% | +130.5% |
| 2020.07 | 2020/06/30 | 修正予 | - | - | - | - | - | - | - | - | - | - | - | - | 360 | ↑ | +131.7% | +131.7% |
| 2020.07 | 2020/06/11 | Q3予 | 400 | → | 0.0% | 0.0% | -1,090 | → | 0.0% | 0.0% | -1,134 | → | 0.0% | 0.0% | -1,137 | → | 0.0% | 0.0% |
| 2020.07 | 2020/03/11 | Q2予 | 400 | → | 0.0% | 0.0% | -1,090 | → | 0.0% | 0.0% | -1,134 | ↓ | -4.0% | 0.0% | -1,137 | → | 0.0% | 0.0% |
| 2020.07 | 2019/12/12 | Q1予 | 400 | → | 0.0% | 0.0% | -1,090 | → | 0.0% | 0.0% | -1,090 | ↑ | +3.9% | +3.9% | -1,137 | → | 0.0% | 0.0% |
| 2020.07 | 2019/09/12 | 当初予 | 400 | - | - | - | -1,090 | - | - | - | -1,134 | - | - | - | -1,137 | - | - | - |
| 2019.07 | 2019/09/12 | 実 | 100 | - | - | - | -726 | - | - | - | -722 | - | - | - | -721 | - | - | - |
